COST UTILITY ANALYSIS OF HPV VACCINATION WITH BIVALENT AS04 ADJUVANT VACCINE IN SLOVAKIA AND IMPACT OF VACCINE PROTECTION DURATION ON COST-EFFECTIVENESS ENDPOINTS

被引：0
|
作者：
Bielik, J. [1 ]
Foltan, V [2 ]
Psenkova, M. [3 ]
Hroncova, D. [4 ]
Marusakova, E. [5 ]
Sadovsky, O. [6 ]
机构：
[1] Fac Hlth, Trencin, Slovakia
[2] Comenius Univ, Bratislava, Slovakia
[3] Spol S Ro, Pharm In, Bratislava, Slovakia
[4] GSK, Noncommercial Educ Ctr, Bratislava, Slovakia
[5] GlaxoSmithKline Slovakia, Bratislava, Slovakia
[6] Natl Oncol Inst, Bratislava, Slovakia
来源：
VALUE IN HEALTH | 2010年 / 13卷 / 07期
关键词：
D O I：
10.1016/S1098-3015(11)73257-0
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A541 / A542
页数：2
相关论文
共 50 条
  • [21] The global impact and cost-effectiveness of a melioidosis vaccine
    Nantasit Luangasanatip
    Stefan Flasche
    David A. B. Dance
    Direk Limmathurotsakul
    Bart J. Currie
    Chiranjay Mukhopadhyay
    Tim Atkins
    Richard Titball
    Mark Jit
    BMC Medicine, 17
  • [22] The global impact and cost-effectiveness of a melioidosis vaccine
    Luangasanatip, Nantasit
    Flasche, Stefan
    Dance, David A. B.
    Limmathurotsakul, Direk
    Currie, Bart J.
    Mukhopadhyay, Chiranjay
    Atkins, Tim
    Titball, Richard
    Jit, Mark
    BMC MEDICINE, 2019, 17
  • [23] An estimate of the public health impact and cost-effectiveness of universal vaccination with a 9-valent HPV vaccine in Germany
    Largeron, Nathalie
    Petry, Karl Ulrich
    Jacob, Jorge
    Bianic, Florence
    Anger, Delphine
    Uhart, Mathieu
    EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH, 2017, 17 (01) : 85 - 98
  • [24] Potential cost-effectiveness of the nonavalent human papillomavirus (HPV) vaccine
    Drolet, Melanie
    Laprise, Jean-Francois
    Boily, Marie-Claude
    Franco, Eduardo L.
    Brisson, Marc
    INTERNATIONAL JOURNAL OF CANCER, 2014, 134 (09) : 2264 - 2268
  • [25] Vaccinating Women Previously Exposed to Human Papillomavirus: A Cost-Effectiveness Analysis of the Bivalent Vaccine
    Turner, Hugo C.
    Baussano, Iacopo
    Garnett, Geoff P.
    PLOS ONE, 2013, 8 (09):
  • [26] Cost-effectiveness analysis of the Lyme vaccine.
    Hsia, EC
    Hurst, SA
    Chung, JB
    Chang, D
    Albert, DA
    ARTHRITIS AND RHEUMATISM, 1999, 42 (09): : S386 - S386
  • [27] Meningococcal vaccine in Portugal - A cost-effectiveness analysis
    Gouveia, M
    Borges, M
    Tavares, L
    Portugal, R
    VALUE IN HEALTH, 2004, 7 (03) : 358 - 358
  • [28] Cost-effectiveness analysis of the Lyme disease vaccine
    Hsia, EC
    Chung, JB
    Schwartz, JS
    Albert, DA
    ARTHRITIS AND RHEUMATISM, 2002, 46 (06): : 1651 - 1660
  • [29] ESTIMATING THE COST-EFFECTIVENESS PROFILE OF A VACCINATION PROGRAMME WITH A NINE-VALENT HPV VACCINE IN ITALY
    Mennini, F. S.
    Bianic, F.
    Baio, G.
    Largeron, N.
    Plazzotta, G.
    Rinaldi, A.
    De Waure, C.
    Bonanni, P.
    VALUE IN HEALTH, 2015, 18 (07) : A457 - A457
  • [30] COST-EFFECTIVENESS OF SEASONAL VACCINATION WITH QUADRIVALENT INFLUENZA VACCINE IN PORTUGAL
    Almeida, J.
    Ferreira, C.
    Monteiro, S.
    VALUE IN HEALTH, 2019, 22 : S651 - S651
12345